CC
INSM icon

Centiva Capital’s Insmed INSM Stock Holding History

Centiva Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,347
Closed -$384K – 2028
2026
Q1 		$384K Buy
2,347
+1,829
+353% +$281K ﹤0.01% 960
2025
Q4 		$90.2K Buy
+518
New +$94.5K ﹤0.01% 1086
2025
Q3 		– Sell
-1,867
Closed -$229K – 1445
2025
Q2 		$188K Buy
+1,867
New +$143K ﹤0.01% 1350
2023
Q3 		– Sell
-9,649
Closed -$204K – 1879
2023
Q2 		$204K Buy
+9,649
New +$183K ﹤0.01% 1329
2021
Q2 		– Sell
-9,135
Closed -$311K – 1494
2021
Q1 		$311K Buy
9,135
+3,101
+51% +$119K 0.01% 743
2020
Q4 		$201K Buy
+6,034
New +$220K 0.01% 783

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Centiva Capital's INSM Position: Q2 2026 in Review

Centiva Capital sold out of Insmed (INSM) in Q2 2026, closing a stake of 2,347 shares — an estimated $384K sold.

Centiva Capital first reported a position in INSM in Q4 2020 and held it in 6 quarters. The position peaked at $384K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Centiva Capital reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 2,347 Insmed shares in Q2 2026, an estimated $384K.
  • Centiva Capital first reported a position in Insmed in Q4 2020 and held it in 6 quarters.
  • Centiva Capital's Insmed position peaked at $384K in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.